Family Medicine & Medical Science Research : Citations & Metrics Report
Articles published in Family Medicine & Medical Science Research have been cited by esteemed scholars and scientists all around the world. Family Medicine & Medical Science Research has got h-index 14, which means every article in Family Medicine & Medical Science Research has got 14 average citations.
Following are the list of articles that have cited the articles published in Family Medicine & Medical Science Research.
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
Year wise published articles |
63 | 11 | 7 | 13 |
Year wise citations received |
112 | 105 | 103 | 66 |
| Journal total citations count | 754 |
| Journal impact factor | 2.67 |
| Journal 5 years impact factor | 4.37 |
| Journal cite score | 4.17 |
| Journal h-index | 14 |
| Journal h-index since 2018 | 13 |
Important citations (454)
Vahed, s. z., aghaee-bakhtiari, s. h., daraei, a., saadatian, z., kafil, h. s., yousefi, b., ... & mansoori, y. (2019). expression pattern of mir-21, mir-25 and pten in peripheral blood mononuclear cells of patients with significant or insignificant coronary stenosis. gene, 698, 170-178. |
|
Melak, t., & baynes, h. w. (2019). circulating micrornas as possible biomarkers for coronary artery disease: a narrative review. ejifcc, 30(2), 179. |
|
Chatziioannou, a., georgiadis, p., hebels, d. g., liampa, i., valavanis, i., bergdahl, i. a., ... & kyrtopoulos, s. a. (2017). blood-based omic profiling supports female susceptibility to tobacco smoke-induced cardiovascular diseases. scientific reports, 7(1), 1-13. |
|
Wallace, r. g., twomey, l. c., custaud, m. a., moyna, n., cummins, p. m., mangone, m., & murphy, r. p. (2016). potential diagnostic and prognostic biomarkers of epigenetic drift within the cardiovascular compartment. biomed research international, 2016. |
|
Kaur, a., mackin, s. t., schlosser, k., wong, f. l., elharram, m., delles, c., ... & pilote, l. (2020). systematic review of microrna biomarkers in acute coronary syndrome and stable coronary artery disease. cardiovascular research, 116(6), 1113-1124. |
|
Siasos, g., bletsa, e., stampouloglou, p. k., oikonomou, e., tsigkou, v., paschou, s. a., ... & tousoulis, d. (2020). micrornas in cardiovascular disease. hellenic journal of cardiology, 61(3), 165-173. |
|
Hecksteden, a., leidinger, p., backes, c., rheinheimer, s., pfeiffer, m., ferrauti, a., ... & keller, a. (2016). mirnas and sports: tracking training status and potentially confounding diagnoses. journal of translational medicine, 14(1), 1-13. |
|
Parizadeh, s. m., ferns, g. a., ghandehari, m., hassanian, s. m., ghayour?mobarhan, m., parizadeh, s. m. r., & avan, a. (2018). the diagnostic and prognostic value of circulating micrornas in coronary artery disease: a novel approach to disease diagnosis of stable cad and acute coronary syndrome. journal of cellular physiology, 233(9), 6418-6424. |
|
Soler-botija, c., gálvez-montón, c., & bayés-genís, a. (2019). epigenetic biomarkers in cardiovascular diseases. frontiers in genetics, 10, 950. |
|
Bian, h., zhou, y., zhou, d., zhang, y., shang, d., & qi, j. (2019). the latest progress on mir?374 and its functional implications in physiological and pathological processes. journal of cellular and molecular medicine, 23(5), 3063-3076. |
|
Mcmanus, d. d., rong, j., huan, t., lacey, s., tanriverdi, k., munson, p. j., ... & levy, d. (2017). messenger rna and microrna transcriptomic signatures of cardiometabolic risk factors. bmc genomics, 18(1), 1-13. |
|
Ahlin, f., arfvidsson, j., vargas, k. g., stojkovic, s., huber, k., & wojta, j. (2016). micrornas as circulating biomarkers in acute coronary syndromes: a review. vascular pharmacology, 81, 15-21. |
|
Pienimaeki?roemer, a., konovalova, t., musri, m. m., sigruener, a., boettcher, a., meister, g., & schmitz, g. (2017). transcriptomic profiling of platelet senescence and platelet extracellular vesicles. transfusion, 57(1), 144-156. |
|
Shah, r., tanriverdi, k., levy, d., larson, m., gerstein, m., mick, e., ... & freedman, j. e. (2016). discordant expression of circulating microrna from cellular and extracellular sources. plos one, 11(4), e0153691. |
|
Song, m. a., paradis, a. n., gay, m. s., shin, j., & zhang, l. (2015). differential expression of micrornas in ischemic heart disease. drug discovery today, 20(2), 223-235. |
|
Rubbo, b., fitzpatrick, n. k., denaxas, s., daskalopoulou, m., yu, n., patel, r. s., ... & outcomes working group. (2015). use of electronic health records to ascertain, validate and phenotype acute myocardial infarction: a systematic review and recommendations. international journal of cardiology, 187, 705-711. |
|
Bekris, l. m., & leverenz, j. b. (2015). the biomarker and therapeutic potential of mirna in alzheimer's disease. neurodegenerative disease management, 5(1), 61-74. |
|
Sárközy, m., kahán, z., & csont, t. (2018). a myriad of roles of mir-25 in health and disease. oncotarget, 9(30), 21580. |
|
Coskunpinar, e., cakmak, h. a., kalkan, a. k., tiryakioglu, n. o., erturk, m., & ongen, z. (2016). circulating mir-221-3p as a novel marker for early prediction of acute myocardial infarction. gene, 591(1), 90-96. |
|
Jakob, p., kacprowski, t., briand-schumacher, s., heg, d., klingenberg, r., stähli, b. e., ... & landmesser, u. (2017). profiling and validation of circulating micrornas for cardiovascular events in patients presenting with st-segment elevation myocardial infarction. european heart journal, 38(7), 511-515. |
|